Curating a Social Biotech Ecosystem Pharmaceutical Business Intelligence
Curating a Social Biotech Ecosystem Pharmaceutical Business Intelligence www. pharmaceuticalintelligence. com @pharma_BI
Who We Are Board Aviva Lev-Ari, Ph. D, RN, Director and Founder Ø Director, Information Analytics Practice, Electronic Commerce Analytics Frameworks and Services, Perot Systems Corporation, Time 0 Group Ø Head of Research - EDAC & Principal Scientist, MITRE Corporation Ø Director of Research, Mc. Graw-Hill Larry Bernstein, MD, FACP, Chief Scientific Officer, Member of the Board Ø Chief, Clinical Pathology at NY Methodist Hospital Ø Professor, Yale University School of Medicine, Department of Laboratory Medicine Marcus Feldman, Ph. D, Member of the Board, Scientific Counsel Ø Professor of Computational Biology, Stanford University, Department of Biology Ø Elected Member, U. S. National Academy of Science Ø Elected Fellow, AAAS • Network organization of ~ 50 Ph. D. , M. D. professionals
Deals, Partnerships Corporate Clients for our Services: Funding Medical Devices Development & Biologics MEDICAL DEVICES • Valve. Cure • Telerescue • STI Laser Industries Ltd • INSYS – INACTIVE AS OF 3/2015 • Alpha. Szenszor Inc • Alpha IP BIOLOGICS § Bioterm Pharmaceutical Ltd. • SBH Science • Invented at HUJI • BIOTECHNOLOGY • CPA Group • Pharmaceutical Informational PLATFORM: ONCOLOGY DRUGS and CLINICAL TRIALS • New Medicine, Inc.
Social Media Press Coverage: Service that we offer to Biotech and Medicine, Scientific and Business Conference Organizers • Conference AGENDA Development • Public Relations, functions defined, below • Event Promotion and REAL TIME Conference Coverage for Biotech Conferences: Scientific, Investment and Partnerships • Conference Analytics Statistics: Number of Views per Presentation, number of tweets per presentations, Aggregate Measures of Tweet. Reach, Word-it-Out Conferences Covered Ø Cambridge Health. Tech Institute’s 14 th Annual Meeting Bio. IT World – Conference & Expo ’ 15, April 21 – 23, 2015, Boston, MA Ø Silicon Valley 2015 Personalized Medicine World Conference, Mountain View, CA Ø 14 th ANNUAL BIOTECH IN EUROPE FORUM For Global Partnering & Investment Basel SACHS Associates, London
Sachs Global Social Analytics
Growing Site and Members Author Views 2012 pharmaceu 198, 936 tical larryhbern 108, 058 tildabarliya 31, 533 sjwilliamspa 19, 461 Dror Nir 16, 616 Dr. Sudipta Saha 16, 090 And Site Metrics ritusaxena 12, 434 TGI 10, 931 aviralvatsa 6, 786 Demet Sag, Ph. D. , CRA, GCP 6, 763 zraviv 06 4, 682 anamikasarkar 2, 861 Subscribers Web: 514 Twitter: 504 Facebook 533 Linked. In: 291
Protecting Your Biotech IP and Market Strategy: Notes from Life Sciences Collaborative 2015 Meeting Achievement Beyond Regulatory Approval – Design for Commercial Success • http: //pharmaceuticalintelligence. com/2015/03/11/protecting-yourbiotech-ip-and-market-strategy-notes-from-life-sciences-collaborative 2015 -meeting/ • LIVE MEETING Coverage • Each Talk Posted on Site with Extra Information added (Links) • Sent Out on Multi. Media Platform (Linked. In Groups, Twitter, Google+ etc) • Gauged Reaction: Very Well received on Social Media
Issues with PA/NJ Biotech Hub Greg Williams, CDO Radius Health From Fierce. Biotech 24 deals 20 biotechs =$265 M ‘More Biotechy? ’ Shire to Move US HQ and 500 Jobs to Greater Boston Shire CEO Flemming Ornskov - Boston Globe From the The Vibrant Philly Biotech Scene Ø “The move was not State influenced by state or industry groups. ” Ø “There could always be more opportunities for networking and collaboration within the Philadelphia community. ” Ø The Philadelphia region has been in many ways hard hit by the shift of drug discovery from large vertically integrated pharmaceutical companies to smaller biotechs Ø “We are a fractioned hub. There are too many silos here”
- Slides: 10